國立虎尾科技大學 |

Probiotic Research in Therapeutics = Volume 5: Metabolic Diseases and Gut Bacteria /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Probiotic Research in Therapeutics/ edited by Kanwaljit Chopra, Mahendra Bishnoi, Kanthi Kiran Kondepudi.
其他題名:	Volume 5: Metabolic Diseases and Gut Bacteria /
其他作者:	Kondepudi, Kanthi Kiran.
面頁冊數:	XIV, 275 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Analytical Chemistry. -
電子資源:	https://doi.org/10.1007/978-981-16-8444-9
ISBN:	9789811684449

Probiotic Research in Therapeutics = Volume 5: Metabolic Diseases and Gut Bacteria /
Probiotic Research in TherapeuticsVolume 5: Metabolic Diseases and Gut Bacteria /[electronic resource] :edited by Kanwaljit Chopra, Mahendra Bishnoi, Kanthi Kiran Kondepudi. - 1st ed. 2022. - XIV, 275 p. 1 illus.online resource.

Chapter 1: Gut-Brain Axis: Role in Hunger and Satiety -- Chapter 2: Antiobesity Activities of Probiotics and Dairy based Ingredients -- Chapter 3: Effect of Pre/Probiotic Supplementation on Metabolic Endotoxemia -- Chapter 4: Probiotics in the management of Diabetes -- Chapter 5: Intestinal microbiota modulation for type 1 and type 2 diabetes prevention -- Chapter 6: Mechanisms of beneficial effects of probiotics in diabetes mellitus -- Chapter 7: Preventive and therapeutic role of Probiotics in type- 2 diabetes and its associated complications -- Chapter 8: Protective effect of probiotic in alcohol induced liver disorders -- Chapter 9: Molecular Mechanism of Beneficial Effects of Probiotics in Alcohol-Induced Liver Disorder -- Chapter 10: Effect of probiotic supplementation on modulation of serum lipids -- Chapter 11: Use of prebiotics for addressing gut dysbiosis and achieving healthy gut- brain axis -- Chapter 12: Designer Probiotics in Metabolic Disorders -- Chapter 13: Animal models used for studying the benefits of probiotics in metabolic disorders.

This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included. The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.

ISBN: 9789811684449

Standard No.: 10.1007/978-981-16-8444-9doiSubjects--Topical Terms:

668584
Analytical Chemistry.

LC Class. No.: RS400-431

Dewey Class. No.: 615.19

Probiotic Research in Therapeutics = Volume 5: Metabolic Diseases and Gut Bacteria /
LDR:03516nam a22003975i 4500 001 1094699
003 DE-He213
005 20220504151110.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811684449 $9 978-981-16-8444-9
024 7 $a 10.1007/978-981-16-8444-9 $2 doi
035 $a 978-981-16-8444-9
050 4 $a RS400-431
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 615.19 $2 23
245 1 0 $a Probiotic Research in Therapeutics $h [electronic resource] : $b Volume 5: Metabolic Diseases and Gut Bacteria / $c edited by Kanwaljit Chopra, Mahendra Bishnoi, Kanthi Kiran Kondepudi.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a XIV, 275 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1: Gut-Brain Axis: Role in Hunger and Satiety -- Chapter 2: Antiobesity Activities of Probiotics and Dairy based Ingredients -- Chapter 3: Effect of Pre/Probiotic Supplementation on Metabolic Endotoxemia -- Chapter 4: Probiotics in the management of Diabetes -- Chapter 5: Intestinal microbiota modulation for type 1 and type 2 diabetes prevention -- Chapter 6: Mechanisms of beneficial effects of probiotics in diabetes mellitus -- Chapter 7: Preventive and therapeutic role of Probiotics in type- 2 diabetes and its associated complications -- Chapter 8: Protective effect of probiotic in alcohol induced liver disorders -- Chapter 9: Molecular Mechanism of Beneficial Effects of Probiotics in Alcohol-Induced Liver Disorder -- Chapter 10: Effect of probiotic supplementation on modulation of serum lipids -- Chapter 11: Use of prebiotics for addressing gut dysbiosis and achieving healthy gut- brain axis -- Chapter 12: Designer Probiotics in Metabolic Disorders -- Chapter 13: Animal models used for studying the benefits of probiotics in metabolic disorders.
520 $a This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included. The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.
650 2 4 $a Analytical Chemistry. $3 668584
650 2 4 $a Health Sciences. $3 1365910
650 1 4 $a Pharmaceutics. $3 1366841
650 0 $a Analytical chemistry. $3 1182118
650 0 $a Pharmacy. $3 582411
650 0 $a Pharmacology. $3 583819
650 0 $a Medical sciences. $3 1208799
650 0 $a Pharmaceutical chemistry. $3 581965
700 1 $a Kondepudi, Kanthi Kiran. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1402868
700 1 $a Bishnoi, Mahendra. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1402867
700 1 $a Chopra, Kanwaljit. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1402866
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811684432
776 0 8 $i Printed edition: $z 9789811684456
776 0 8 $i Printed edition: $z 9789811684463
856 4 0 $u https://doi.org/10.1007/978-981-16-8444-9
912 $a ZDB-2-CMS
912 $a ZDB-2-SXC
950 $a Chemistry and Materials Science (SpringerNature-11644)
950 $a Chemistry and Material Science (R0) (SpringerNature-43709)